Ontology type: schema:ScholarlyArticle Open Access: True
2019-12
AUTHORSJayne Moxey, Molla Huq, Susanna Proudman, Joanne Sahhar, Gene-Siew Ngian, Jenny Walker, Gemma Strickland, Michelle Wilson, Laura Ross, Gabor Major, Janet Roddy, Wendy Stevens, Mandana Nikpour
ABSTRACTBACKGROUND: Up to 12% of patients with systemic sclerosis (SSc) have anti-neutrophil cytoplasmic antibodies (ANCA). However, the majority of these patients do not manifest ANCA-associated vasculitis (AAV) and the significance of ANCA in these patients is unclear. The aim of this study is to determine the prevalence of ANCA in a well-characterised SSc cohort and to examine the association between ANCA and SSc clinical characteristics, other autoantibodies, treatments and mortality. METHODS: Clinical data were obtained from 5 centres in the Australian Scleroderma Cohort Study (ASCS). ANCA positive was defined as the presence of any one or combination of cytoplasmic ANCA (c-ANCA), perinuclear ANCA (p-ANCA), atypical ANCA, anti-myeloperoxidase (anti-MPO) or anti-proteinase-3 (anti-PR3). Associations of demographic and clinical features with ANCA were investigated by logistic or linear regression. Survival analysis was performed using Kaplan-Meyer curves and Cox regression models. RESULTS: Of 1303 patients, 116 (8.9%) were ANCA positive. Anti-PR3 was more common than anti-MPO (13.8% and 11.2% of ANCA-positive patients, respectively). Only 3 ANCA-positive patients had AAV. Anti-Scl-70 was more common in ANCA positive vs ANCA negative (25% vs 12.8%, p < 0.001), anti-MPO positive vs anti-MPO negative (38.5% vs 13.6%, p = 0.006) and anti-PR3 positive vs anti-PR3 negative patients (44.4% vs 13.4%, p < 0.001). A higher prevalence of interstitial lung disease (ILD) was found in the ANCA positive (44.8% vs 21.8%, p < 0.001) and the anti-PR3 positive groups (50.0% vs 23.4%, p = 0.009). In multivariable analysis, ANCA-positive status remained associated with ILD after adjusting for anti-Scl-70 antibodies. Pulmonary embolism (PE) was more common in ANCA-positive patients (8.6% vs 3.0%, p = 0.002) and anti-PR3-positive patients (16.7% vs 3.3%, p = 0.022). ANCA-positive status remained associated with PE in a multivariable analysis adjusting for anti-phospholipid antibodies. Kaplan-Meier analysis revealed increased mortality in ANCA-positive patients (p = 0.006). In Cox regression analysis, ANCA was associated with increased mortality, after adjusting for age and sex. CONCLUSIONS: ANCA is associated with increased prevalence of ILD and PE in SSc. ANCA should be tested in SSc, as it identifies individuals with worse prognosis who require close monitoring for adverse outcomes. More... »
PAGES57
http://scigraph.springernature.com/pub.10.1186/s13075-019-1839-5
DOIhttp://dx.doi.org/10.1186/s13075-019-1839-5
DIMENSIONShttps://app.dimensions.ai/details/publication/pub.1112139062
PUBMEDhttps://www.ncbi.nlm.nih.gov/pubmed/30764870
JSON-LD is the canonical representation for SciGraph data.
TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT
[
{
"@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json",
"about": [
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Clinical Sciences",
"type": "DefinedTerm"
},
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Medical and Health Sciences",
"type": "DefinedTerm"
}
],
"author": [
{
"affiliation": {
"alternateName": "St Vincent's Hospital",
"id": "https://www.grid.ac/institutes/grid.413105.2",
"name": [
"The University of Melbourne, 41 Victoria Parade Fitzroy, 3065, Melbourne, Victoria, Australia",
"St. Vincent\u2019s Hospital Melbourne, 41 Victoria Parade Fitzroy, 3065, Melbourne, Victoria, Australia"
],
"type": "Organization"
},
"familyName": "Moxey",
"givenName": "Jayne",
"type": "Person"
},
{
"affiliation": {
"alternateName": "University of Melbourne",
"id": "https://www.grid.ac/institutes/grid.1008.9",
"name": [
"The University of Melbourne, 41 Victoria Parade Fitzroy, 3065, Melbourne, Victoria, Australia"
],
"type": "Organization"
},
"familyName": "Huq",
"givenName": "Molla",
"type": "Person"
},
{
"affiliation": {
"alternateName": "Royal Adelaide Hospital",
"id": "https://www.grid.ac/institutes/grid.416075.1",
"name": [
"University of Adelaide, Adelaide, South Australia, Australia",
"Royal Adelaide Hospital, Adelaide, South Australia, Australia"
],
"type": "Organization"
},
"familyName": "Proudman",
"givenName": "Susanna",
"type": "Person"
},
{
"affiliation": {
"alternateName": "Monash University",
"id": "https://www.grid.ac/institutes/grid.1002.3",
"name": [
"Monash Health, Melbourne, Victoria, Australia",
"Monash University, Melbourne, Victoria, Australia"
],
"type": "Organization"
},
"familyName": "Sahhar",
"givenName": "Joanne",
"type": "Person"
},
{
"affiliation": {
"alternateName": "Monash University",
"id": "https://www.grid.ac/institutes/grid.1002.3",
"name": [
"Monash Health, Melbourne, Victoria, Australia",
"Monash University, Melbourne, Victoria, Australia"
],
"type": "Organization"
},
"familyName": "Ngian",
"givenName": "Gene-Siew",
"type": "Person"
},
{
"affiliation": {
"alternateName": "Flinders Medical Centre",
"id": "https://www.grid.ac/institutes/grid.414925.f",
"name": [
"Flinders Medical Centre, Adelaide, South Australia, Australia"
],
"type": "Organization"
},
"familyName": "Walker",
"givenName": "Jenny",
"type": "Person"
},
{
"affiliation": {
"name": [
"Barwon Rheumatology Service, Geelong, Victoria, Australia"
],
"type": "Organization"
},
"familyName": "Strickland",
"givenName": "Gemma",
"type": "Person"
},
{
"affiliation": {
"alternateName": "St Vincent's Hospital",
"id": "https://www.grid.ac/institutes/grid.413105.2",
"name": [
"St. Vincent\u2019s Hospital Melbourne, 41 Victoria Parade Fitzroy, 3065, Melbourne, Victoria, Australia"
],
"type": "Organization"
},
"familyName": "Wilson",
"givenName": "Michelle",
"type": "Person"
},
{
"affiliation": {
"alternateName": "St Vincent's Hospital",
"id": "https://www.grid.ac/institutes/grid.413105.2",
"name": [
"The University of Melbourne, 41 Victoria Parade Fitzroy, 3065, Melbourne, Victoria, Australia",
"St. Vincent\u2019s Hospital Melbourne, 41 Victoria Parade Fitzroy, 3065, Melbourne, Victoria, Australia"
],
"type": "Organization"
},
"familyName": "Ross",
"givenName": "Laura",
"type": "Person"
},
{
"affiliation": {
"alternateName": "University of Newcastle Australia",
"id": "https://www.grid.ac/institutes/grid.266842.c",
"name": [
"Royal Newcastle Centre John Hunter Hospital, Newcastle, New South Wales, Australia",
"University of Newcastle, Newcastle, New South Wales, Australia"
],
"type": "Organization"
},
"familyName": "Major",
"givenName": "Gabor",
"type": "Person"
},
{
"affiliation": {
"alternateName": "Fiona Stanley Hospital",
"id": "https://www.grid.ac/institutes/grid.459958.c",
"name": [
"Fiona Stanley Hospital, Perth, Western Australia, Australia"
],
"type": "Organization"
},
"familyName": "Roddy",
"givenName": "Janet",
"type": "Person"
},
{
"affiliation": {
"alternateName": "St Vincent's Hospital",
"id": "https://www.grid.ac/institutes/grid.413105.2",
"name": [
"St. Vincent\u2019s Hospital Melbourne, 41 Victoria Parade Fitzroy, 3065, Melbourne, Victoria, Australia"
],
"type": "Organization"
},
"familyName": "Stevens",
"givenName": "Wendy",
"type": "Person"
},
{
"affiliation": {
"alternateName": "St Vincent's Hospital",
"id": "https://www.grid.ac/institutes/grid.413105.2",
"name": [
"The University of Melbourne, 41 Victoria Parade Fitzroy, 3065, Melbourne, Victoria, Australia",
"St. Vincent\u2019s Hospital Melbourne, 41 Victoria Parade Fitzroy, 3065, Melbourne, Victoria, Australia"
],
"type": "Organization"
},
"familyName": "Nikpour",
"givenName": "Mandana",
"type": "Person"
}
],
"citation": [
{
"id": "https://doi.org/10.1016/1040-8428(96)00202-8",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1002112517"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.2169/internalmedicine.53.1599",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1003496238"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1186/1752-1947-2-151",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1007227580",
"https://doi.org/10.1186/1752-1947-2-151"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1136/annrheumdis-2013-204424",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1007344405"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1136/ard.53.1.24",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1010428921"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1093/rheumatology/ken035",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1017892968"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1097/mnh.0b013e3283456731",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1021246444"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1097/mnh.0b013e3283456731",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1021246444"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/s00296-008-0675-8",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1022073145",
"https://doi.org/10.1007/s00296-008-0675-8"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/s00296-008-0675-8",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1022073145",
"https://doi.org/10.1007/s00296-008-0675-8"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1016/s1297-319x(02)00367-6",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1024388930"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/s00296-011-2359-z",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1028800213",
"https://doi.org/10.1007/s00296-011-2359-z"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/s00296-005-0011-5",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1032424176",
"https://doi.org/10.1007/s00296-005-0011-5"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/s00296-005-0011-5",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1032424176",
"https://doi.org/10.1007/s00296-005-0011-5"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/s00296-005-0011-5",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1032424176",
"https://doi.org/10.1007/s00296-005-0011-5"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1186/2193-1801-3-513",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1033657689",
"https://doi.org/10.1186/2193-1801-3-513"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1093/rheumatology/ket213",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1040955670"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1172/jci31139",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1041654026"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1016/s0272-6386(97)90065-2",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1044233203"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1097/md.0b013e31827781fd",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1045197934"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1097/md.0b013e31827781fd",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1045197934"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1097/bor.0b013e3283588dcf",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1047828609"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1097/bor.0b013e3283588dcf",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1047828609"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1016/j.semarthrit.2010.11.001",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1049760256"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1155/2010/148528",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1052286861"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/s11926-004-0061-9",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1052404542",
"https://doi.org/10.1007/s11926-004-0061-9"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.3899/jrheum.140006",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1071543446"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.4081/rr.2011.e2",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1072203203"
],
"type": "CreativeWork"
},
{
"id": "https://app.dimensions.ai/details/publication/pub.1075056065",
"type": "CreativeWork"
},
{
"id": "https://app.dimensions.ai/details/publication/pub.1075199478",
"type": "CreativeWork"
},
{
"id": "https://app.dimensions.ai/details/publication/pub.1075295640",
"type": "CreativeWork"
},
{
"id": "https://app.dimensions.ai/details/publication/pub.1077267465",
"type": "CreativeWork"
},
{
"id": "https://app.dimensions.ai/details/publication/pub.1079704019",
"type": "CreativeWork"
},
{
"id": "https://app.dimensions.ai/details/publication/pub.1082634035",
"type": "CreativeWork"
},
{
"id": "https://app.dimensions.ai/details/publication/pub.1083034533",
"type": "CreativeWork"
}
],
"datePublished": "2019-12",
"datePublishedReg": "2019-12-01",
"description": "BACKGROUND: Up to 12% of patients with systemic sclerosis (SSc) have anti-neutrophil cytoplasmic antibodies (ANCA). However, the majority of these patients do not manifest ANCA-associated vasculitis (AAV) and the significance of ANCA in these patients is unclear. The aim of this study is to determine the prevalence of ANCA in a well-characterised SSc cohort and to examine the association between ANCA and SSc clinical characteristics, other autoantibodies, treatments and mortality.\nMETHODS: Clinical data were obtained from 5 centres in the Australian Scleroderma Cohort Study (ASCS). ANCA positive was defined as the presence of any one or combination of cytoplasmic ANCA (c-ANCA), perinuclear ANCA (p-ANCA), atypical ANCA, anti-myeloperoxidase (anti-MPO) or anti-proteinase-3 (anti-PR3). Associations of demographic and clinical features with ANCA were investigated by logistic or linear regression. Survival analysis was performed using Kaplan-Meyer curves and Cox regression models.\nRESULTS: Of 1303 patients, 116 (8.9%) were ANCA positive. Anti-PR3 was more common than anti-MPO (13.8% and 11.2% of ANCA-positive patients, respectively). Only 3 ANCA-positive patients had AAV. Anti-Scl-70 was more common in ANCA positive vs ANCA negative (25% vs 12.8%, p\u2009<\u20090.001), anti-MPO positive vs anti-MPO negative (38.5% vs 13.6%, p\u2009=\u20090.006) and anti-PR3 positive vs anti-PR3 negative patients (44.4% vs 13.4%, p\u2009<\u20090.001). A higher prevalence of interstitial lung disease (ILD) was found in the ANCA positive (44.8% vs 21.8%, p\u2009<\u20090.001) and the anti-PR3 positive groups (50.0% vs 23.4%, p\u2009=\u20090.009). In multivariable analysis, ANCA-positive status remained associated with ILD after adjusting for anti-Scl-70 antibodies. Pulmonary embolism (PE) was more common in ANCA-positive patients (8.6% vs 3.0%, p\u2009=\u20090.002) and anti-PR3-positive patients (16.7% vs 3.3%, p\u2009=\u20090.022). ANCA-positive status remained associated with PE in a multivariable analysis adjusting for anti-phospholipid antibodies. Kaplan-Meier analysis revealed increased mortality in ANCA-positive patients (p\u2009=\u20090.006). In Cox regression analysis, ANCA was associated with increased mortality, after adjusting for age and sex.\nCONCLUSIONS: ANCA is associated with increased prevalence of ILD and PE in SSc. ANCA should be tested in SSc, as it identifies individuals with worse prognosis who require close monitoring for adverse outcomes.",
"genre": "research_article",
"id": "sg:pub.10.1186/s13075-019-1839-5",
"inLanguage": [
"en"
],
"isAccessibleForFree": true,
"isPartOf": [
{
"id": "sg:journal.1297499",
"issn": [
"1478-6354",
"1478-6362"
],
"name": "Arthritis Research & Therapy",
"type": "Periodical"
},
{
"issueNumber": "1",
"type": "PublicationIssue"
},
{
"type": "PublicationVolume",
"volumeNumber": "21"
}
],
"name": "Significance of anti-neutrophil cytoplasmic antibodies in systemic sclerosis",
"pagination": "57",
"productId": [
{
"name": "readcube_id",
"type": "PropertyValue",
"value": [
"811f1de57a3dab6f8b6b8e04e7a26c33e9e633e6ec2812dcf88850372e65e6d9"
]
},
{
"name": "pubmed_id",
"type": "PropertyValue",
"value": [
"30764870"
]
},
{
"name": "nlm_unique_id",
"type": "PropertyValue",
"value": [
"101154438"
]
},
{
"name": "doi",
"type": "PropertyValue",
"value": [
"10.1186/s13075-019-1839-5"
]
},
{
"name": "dimensions_id",
"type": "PropertyValue",
"value": [
"pub.1112139062"
]
}
],
"sameAs": [
"https://doi.org/10.1186/s13075-019-1839-5",
"https://app.dimensions.ai/details/publication/pub.1112139062"
],
"sdDataset": "articles",
"sdDatePublished": "2019-04-11T10:22",
"sdLicense": "https://scigraph.springernature.com/explorer/license/",
"sdPublisher": {
"name": "Springer Nature - SN SciGraph project",
"type": "Organization"
},
"sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000348_0000000348/records_54338_00000002.jsonl",
"type": "ScholarlyArticle",
"url": "https://link.springer.com/10.1186%2Fs13075-019-1839-5"
}
]Download the RDF metadata as: json-ld nt turtle xml License info
JSON-LD is a popular format for linked data which is fully compatible with JSON.
curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/s13075-019-1839-5'
N-Triples is a line-based linked data format ideal for batch operations.
curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/s13075-019-1839-5'
Turtle is a human-readable linked data format.
curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/s13075-019-1839-5'
RDF/XML is a standard XML format for linked data.
curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/s13075-019-1839-5'
This table displays all metadata directly associated to this object as RDF triples.
250 TRIPLES
21 PREDICATES
58 URIs
21 LITERALS
9 BLANK NODES